135 related articles for article (PubMed ID: 14993313)
1. Identification of a topoisomerase IV in actinobacteria: purification and characterization of ParYR and GyrBR from the coumermycin A1 producer Streptomyces rishiriensis DSM 40489.
Schmutz E; Hennig S; Li SM; Heide L
Microbiology (Reading); 2004 Mar; 150(Pt 3):641-647. PubMed ID: 14993313
[TBL] [Abstract][Full Text] [Related]
2. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
Schmutz E; Mühlenweg A; Li SM; Heide L
Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
[TBL] [Abstract][Full Text] [Related]
3. Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489.
Wang ZX; Li SM; Heide L
Antimicrob Agents Chemother; 2000 Nov; 44(11):3040-8. PubMed ID: 11036020
[TBL] [Abstract][Full Text] [Related]
4. DNA gyrase and DNA topoisomerase of Bacillus subtilis: expression and characterization of recombinant enzymes encoded by the gyrA, gyrB and parC, parE genes.
Barnes MH; LaMarr WA; Foster KA
Protein Expr Purif; 2003 Jun; 29(2):259-64. PubMed ID: 12767818
[TBL] [Abstract][Full Text] [Related]
5. What makes a type IIA topoisomerase a gyrase or a Topo IV?
Hirsch J; Klostermeier D
Nucleic Acids Res; 2021 Jun; 49(11):6027-6042. PubMed ID: 33905522
[TBL] [Abstract][Full Text] [Related]
6. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
Hsu YH; Chung MW; Li TK
Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
[TBL] [Abstract][Full Text] [Related]
7. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
Hardy CD; Cozzarelli NR
Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
[TBL] [Abstract][Full Text] [Related]
8. An unusual amide synthetase (CouL) from the coumermycin A1 biosynthetic gene cluster from Streptomyces rishiriensis DSM 40489.
Schmutz E; Steffensky M; Schmidt J; Porzel A; Li SM; Heide L
Eur J Biochem; 2003 Nov; 270(22):4413-9. PubMed ID: 14622269
[TBL] [Abstract][Full Text] [Related]
9. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
Fujimoto-Nakamura M; Ito H; Oyamada Y; Nishino T; Yamagishi J
Antimicrob Agents Chemother; 2005 Sep; 49(9):3810-5. PubMed ID: 16127057
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of three topoisomerases that regulate DNA supercoiling levels in Chlamydia.
Orillard E; Tan M
Mol Microbiol; 2016 Feb; 99(3):484-96. PubMed ID: 26447825
[TBL] [Abstract][Full Text] [Related]
12. A naturally chimeric type IIA topoisomerase in Aquifex aeolicus highlights an evolutionary path for the emergence of functional paralogs.
Tretter EM; Lerman JC; Berger JM
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22055-9. PubMed ID: 21076033
[TBL] [Abstract][Full Text] [Related]
13. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
14. A GyrB-GyrA fusion protein expressed in yeast cells is able to remove DNA supercoils but cannot substitute eukaryotic topoisomerase II.
Trigueros S; Roca J
Genes Cells; 2002 Mar; 7(3):249-57. PubMed ID: 11918669
[TBL] [Abstract][Full Text] [Related]
15. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
[TBL] [Abstract][Full Text] [Related]
16. Expression and analysis of two gyrB genes from the novobiocin producer, Streptomyces sphaeroides.
Thiara AS; Cundliffe E
Mol Microbiol; 1993 May; 8(3):495-506. PubMed ID: 8392138
[TBL] [Abstract][Full Text] [Related]
17. Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress.
Colgan AM; Quinn HJ; Kary SC; Mitchenall LA; Maxwell A; Cameron ADS; Dorman CJ
Mol Microbiol; 2018 Mar; 107(6):734-746. PubMed ID: 29352745
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
[TBL] [Abstract][Full Text] [Related]
19. Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.
Battisti JM; Smitherman LS; Samuels DS; Minnick MF
Antimicrob Agents Chemother; 1998 Nov; 42(11):2906-13. PubMed ID: 9797224
[TBL] [Abstract][Full Text] [Related]
20. First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.
Aubry A; Fisher LM; Jarlier V; Cambau E
Biochem Biophys Res Commun; 2006 Sep; 348(1):158-65. PubMed ID: 16876125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
